About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
M
Outcomes From ALEX and ALESIA Trials on Alectinib in ALK+ NSCLC
By
Malinda Itchins
2 Videos
325 views
May 28, 2021
0 Comments
Login to view comments.
Click here to Login
Featured Video
09:36
Johnson & Johnson
Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSC…
Feat.
J. Heymach,
M. Das
Featured Video
06:27
Johnson & Johnson
Challenges to Navigate in Locally Advanced or Metastatic EGFR+ NSCLC
Feat.
M. Socinski,
D. Waterhouse
Related Content
AUTOPLAY
ON
17:34
ecancer
Recent NSCLC Updates Including PAPILLON, CHECKMATE 77T, and KEYNOTE-…
Feat.
L. Raez
16:10
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Lung Cancer Highlights: CROWN, LAURA, ADRIATIC, and PALOM…
Feat.
L. Raez
26:21
Memorial Sloan Kettering Cancer Center
NSCLC & Targeted Therapy: A Brief Overview and Update in the Met…
Feat.
M. Hwang
16:57
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NS…
Feat.
V. Subbiah
20:52
Total Health
Diagnostics in Lung Cancer: A Comprehensive Discussion - Best of Lun…
Feat.
T. Boyle
20:27
Yale Cancer Center
Progress in the Treatment of NSCLC
Feat.
R. Herbst
18:09
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis
The Changing Prognosis of Lung Cancer Brain Metastases
Feat.
S. Goldberg
08:15
ecancer
ESMO 2023 Summary: "Highlights From Recent NSCLC Trials"
Feat.
B. Gyawali
12:26
Scripps Health
2024 Neuro-Oncology Update: NSCLC and Brain Mets
Feat.
T. McGranahan
04:31
Integrity Continuing Education
Neoadjuvant and Adjuvant Treatment in Early Stage NSCLC: Options Are…
Feat.
J. Gainor,
J. Sands
23:17
OncoAlert
Early NSCLC Updates: EGFRm, ALK+ Disease & Neoadjuvant IO
Feat.
G. Lopes
10:14
UChicago Medicine 12th International Clinical Cancer Genomics Conference
Precision Medicine in NSCLC
Feat.
S. Gray
11:39
Insights from ELCC 2024
ELCC 2024 Insights: "Small Numbers, Big Impact - The Importance…
Feat.
L. Brcic
17:44
Total Health
Novel Approaches in the Treatment of NSCLC
Feat.
E. Massarelli
10:55
Yale Cancer Center
Lung Cancer Updates: The Role of Surgery After Neoadjuvant Systemic …
Feat.
C. Balch
18:14
ILCC 2022 Conference Coverage
Systemic Therapy for Brain Metastases in NSCLC
Feat.
E. Massarelli
40:59
University of Colorado Cancer Center
Cancer 'Super-Survivors': ALK+ NSCLC
Feat.
R. Camidge
12:15
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "ATTLAS Study of Atezolizumab + Bevacizumab…
Feat.
M. Ahn
33:37
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course
Fred Hutchinson Cancer Center Review of Metastatic NSCLC
Feat.
C. Baik
21:35
Total Health
Management of Advanced NSCLC: IO, Targeted Therapy, and Beyond
Feat.
T. Patil